Schall Law Firm investigates Certara
Analysis based on 6 articles · First reported May 24, 2026 · Last updated Jun 11, 2026
The investigation into Certara for alleged securities law violations and the 19% drop in its shares directly impact Certara's stock price negatively. This event also highlights potential risks for investors in the biotechnology and pharmaceutical sectors, leading to increased scrutiny of financial reporting.
The Schall Law Firm has launched an investigation into Certara, Inc. for alleged violations of securities laws. This follows Certara's Q1 2026 financial results, reported on May 11, 2026, which showed a significant decline in services revenues and bookings. The company attributed this to 'softer performance from Tier 1 customers in MIDD services'. Following this announcement, Certara's shares (Nasdaq-100: CERT) plummeted by 19% on the same day. The Schall Law Firm, led by Brian Schall, is encouraging affected shareholders to participate in the investigation, specializing in securities class action lawsuits and shareholder rights litigation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard